Uji, Akihito
Sadda, SriniVas R.
Muraoka, Yuki
Kadomoto, Shin
Ooto, Sotaro
Murakami, Tomoaki
Akagi, Tadamichi
Miyata, Manabu
Tsujikawa, Akitaka
Article History
Received: 26 November 2019
Revised: 15 April 2020
Accepted: 21 April 2020
First Online: 2 May 2020
Compliance with ethical standards
:
: Akihito Uji, Alcon (Recipient), Senju (Recipient), Canon (Recipient); SriniVas R. Sadda, Carl Zeiss Meditec (Financial Support), Optos (Financial Support, Consultant), Allergan (Financial Support, Consultant), Genentech (Financial Support, Consultant), Alcon (Consultant); Novartis (Consultant); Roche (Consultant), Regeneron (Consultant), Bayer (Consultant), Thrombogenics (Consultant), Stemm Cells, Inc. (Consultant), Avalanche (Consultant); Yuki Muraoka, Bayer (Recipient), Novartis Pharma K.K. (Recipient), Senju (Recipient), Nidek (Recipient); Shin Kadomoto, Nidek (Recipient), Canon (Recipient); Sotaro Ooto, Novartis Pharma K.K. (Recipient), Bayer (Recipient), Santen (Recipient), Senju (Recipient); Tomoaki Murakami, Bayer (Recipient), Novartis Pharma K.K. (Recipient), Santen (Recipient), Senju (Recipient); Tadamichi Akagi, Alcon (Recipient), Kowa (Recipient), Pfizer (Recipient), Santen (Recipient), Senju (Recipient), Canon (Recipient); Akitaka Tsujikawa, Pfizer (Financial Support, Recipient), Novartis Pharma K.K. (Financial Support, Recipient), Bayer (Financial Support, Recipient), Alcon (Financial Support, Recipient), Santen (Financial Support, Recipient), Senju (Financial Support, Recipient), Nidek (Recipient), Kowa (Financial Support, Recipient), Hoya (Financial Support, Recipient), AMO Japan (Financial Support, Recipient).
: All study procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual study participants.